key: cord-0851643-fc137790
authors: Zhang, S. X. O.; Miller, S. O.; Xu, W.; Yin, A.; Chen, B.; Delios, A.; Dong, R. K.; Chen, R. Z.; McIntyre, R.; Wan, X.; Wang, S.; Chen, J.
title: Meta-Analytic Evidence of Depression and Anxiety in Eastern Europe during the COVID-19 Pandemic
date: 2021-06-25
journal: nan
DOI: 10.1101/2021.06.21.21259227
sha: e9c07afd9c529d3d277ef49e2833745c151e19e8
doc_id: 851643
cord_uid: fc137790

Objective: To perform a systematic and meta-analysis on the prevalence rates of mental health symptoms including anxiety and depression during the COVID-19 pandemic in the general population in Eastern Europe, as well as three select sub-populations: students, general healthcare workers, and frontline healthcare workers. Data sources: Studies in PubMed, Embase, Web of Science, Psycinfo, and medRxiv up to February 6, 2021. Eligibility criteria and data analysis: Prevalence rates of mental health symptoms in the general population and key sub-populations during the COVID-19 pandemic in Eastern Europe. Data were pooled using a random-effects meta-analysis to estimate the prevalence rates of anxiety and depression. Results: The meta-analysis identifies and includes 21 studies and 26 independent samples in Eastern Europe. Poland (n=4), Serbia (n=4), Russia (n=3), and Croatia (n=3) had the greatest number of studies. To our knowledge, no studies have been conducted in eleven Eastern European countries including Hungary, Slovakia, and Slovenia. The pooled prevalence of anxiety in 18 studies with 22 samples was 30% (95% CI: 24%-37%) and pooled prevalence of depression in 18 studies with 23 samples was 27% (95% CI: 21%-34%). Implications: The cumulative evidence from the meta-analysis reveals high prevalence rates of clinically significant symptoms during the COVID-19 pandemic in Eastern Europe. The findings suggest evidence of a potential mental health crisis in Eastern Europe during the ongoing COVID-19 pandemic. Our synthesis also reveals a relative lack of studies in certain Eastern European countries as well as high heterogeneities among the existing studies, calling for more effort to achieve evidence-based mental healthcare in Eastern Europe. Keywords: COVID-19; Epidemic; General Population; Healthcare Workers; Frontline Healthcare Workers; Psychiatry Highlights: The pooled prevalence of anxiety and depression were 30% and 27% in Eastern Europe, respectively.

The COVID-19 pandemic (1), with more than 170 million confirmed cases and 3.5 million deaths by May 2021 (2) , has taken a toll on mental health, due to fear of illness and hospitalization, the effects of social isolation, and economic downturn (2, 3) . To assess mental health during the COVID-19 pandemic, several meta-analyses have polled the prevalence of mental health symptoms in several countries or regions, such as China (4), Southeast Asia (5), and South Asia (6) . These meta-analytical studies have provided crucial evidence on mental health in specific regions and uncovered important heterogeneity to enable evidence-based healthcare in those regions. However, the literature still lacks meta-analytical evidence on the prevalence of mental health symptoms in Eastern Europe -a vast region that has been affected by the COVID-19 pandemic in the past year. Eastern Europe has struggled to manage the pandemic, and has suffered from high mortality and morbidity rates. Mental health research has historically overlooked Eastern Europe (7) , where mental health epidemiology is still regarded with intense stigma and direct evidence on the topic remains scarce (8) . Even prior to the pandemic, Eastern Europe has been relatively weak in identifying people with mental health symptoms (7) . Furthermore, recent changes in healthcare systems and lack of per capita funding for community mental health resources presents some unique issues in mental health practice at the system level in Eastern Europe (7) . Such issues have resulted in a lack of evidence-based mental health practices (8) .

This study aims to address this knowledge gap by presenting the first meta-analysis to quantify the prevalence of anxiety and depression during the COVID-19 pandemic in Eastern Europe. We performed a systematic review of the prevalence of anxiety and depression of the general population as well as healthcare workers (HCW) during the COVID-19 pandemic in . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 25, 2021. ; https://doi.org/10.1101/2021.06.21.21259227 doi: medRxiv preprint Eastern European countries. Such meta-analytical pooled prevalence of mental health symptoms provides crucial evidence to enable evidence-based healthcare policies and resource deployment and also creates opportunities for decision-making on prevention.

This systematic review and meta-analysis follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement 2019 and is registered in the International Prospective Register of Systematic Reviews (PROSPERO: CRD42020224458) (9).

A comprehensive literature search was performed in the following databases: Web of Science, PUBMED, EMBASE, and medRxiv based on keywords shown in Appendix 1 with Boolean operators.

The articles were selected based on the following criteria: 3. Methodological approaches: Non-primary studies including reviews, meta-analyses, qualitative studies, case studies, interventional studies, interviews, or news reports.

Two coders (BZC & AD) independently reviewed titles and abstracts of empirical studies retrieved through initial screening criteria. Conflicts of eligibility were referred to a third coder (RKD). The articles included after the title and abstract screening underwent a full-text evaluation.

A comprehensive screening protocol was developed. The following variables were collected from each study: author, title, country, starting and ending dates of data collection, study design, population, sample size, respondent rate, female proportion rate, age range and mean, outcome, outcome level, instruments, cut-off scores, and prevalence. If possible, we coded the prevalence at the severity of mild above, moderate above, and severe. For those studies that reported the mild, moderate, and severe prevalence, we converted them into mild above, . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 25, 2021. ; https://doi.org/10.1101/2021.06.21.21259227 doi: medRxiv preprint moderate above, and severe prevalence. For these studies that only reported the overall prevalence, we specified their severity if their cut-off points were reported.

RZC & SM). The corresponding authors of empirical studies without prevalence data or missing essential data were contacted by a designated researcher (WX). The reason(s) for emailing authors and excluding studies were recorded. After both coders in each pair had independently coded their studies, they then cross-checked their information and discussed possible differences.

If disagreements remained, a third coder (SM) settled disagreements after independently coding the study.

Risk of bias was assessed at the empirical article collection and meta-analysis level.

Throughout the data collection process, two coders used the Mixed Methods Appraisal Tool (MMAT) to independently determine the appropriateness of measurement tools, the risk of nonresponse bias, and the sample representativeness of each empirical study (10) . A quality score ranging from 0 to 7 was assigned to each empirical study. A MMAT quality score higher than 6 indicated low bias risk, a score between 5 and 6 indicated medium risk, and a score below 5 indicated high bias risk (10) . The MMAT scores were compared using a standardized crosscheck protocol. A final check of inter-coder consistency was performed by a third independent coder (RKD). A sensitivity analysis was conducted to assess the risk of bias of the study.

Stata 16.1 was used to pool rates of anxiety and depression, using metaprop (11) . The random-effects model was used to calculate pooled estimates of outcome prevalence between populations. The I 2 statistic was used to calculate variance difference from effect sizes in order to . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 25, 2021. ; https://doi.org/10.1101/2021.06.21.21259227 doi: medRxiv preprint quantify heterogeneity rather than sampling error (12) . Subgroup analyses were performed on population groups (i.e., general population, students, general HCWs, and frontline HCWs), mental health disorder (i.e., anxiety, depression, and insomnia), outcome severity (i.e., mild above, moderate above, severe). We also performed subgroup analysis on EU ( 

A PRISMA flowchart ( Figure 1 ) illustrates the systematic review process, which is part of a large research effort to examine the prevalence of mental health symptoms across regions and countries during the COVID-19 pandemic. A total of 6949 studies were identified in the search. Of these studies, 3603 were duplicates and were excluded. The initial screening of 3346 studies produced 684 studies eligible for further full-text evaluation. Through detailed full-text evaluation, 524 studies were excluded. Two rounds of emails were sent to the authors of studies with missing data for the meta-analyses. Prevalence data from the email responses was added to 8 of the 29 empirical studies, bringing the total number of empirical studies for the meta-analyses to 168. Of the 168 studies, 23 empirical studies covered Eastern Europe . As there were only two studies that examined the prevalence of insomnia (19, 22) , insomnia was excluded from further analysis. The meta-analysis included the remaining 21 studies with 26 unique samples . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 25, 2021. Table 1 shows the characteristics of the 21 studies. The countries that had the most studies are Poland and Serbia (19.1%, n=4), followed by Croatia and Russia (14.39%, n=3), Albania (9.5%, n=2), and one study each from Bosnia and Herzegovina, Bulgaria, Czech Republic, Kosovo, and Ukraine. Samples were distributed between populations as follows:

general population (42.3%, n=11), general HCWs (26.9%, n=7), general (i.e. non-medical) students (15.4%, n=4), and frontline HCWs (15.4%, n=4). The prevalence of mental health symptoms was found for the following categories: mild above (34.5%, n=30), moderate above (37.9%, n=33), severe above (19.6%, n=17), and overall (8.1%, n=7). Most of the studies (95.7%, n=20) used cross-sectional designs. The median percentage of female respondents was 68.8% with a range of 0% to 100%. The response rates ranged from 0.7% to 98.5% with a median of 56.7%. The sample size ranged from 83 to 3306 with a median of 843 respondents.

A random-effects meta-analysis model showed the pooled prevalence of depression of 18 empirical studies (13, (15) (16) (17) (18) (19) (20) (21) (22) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (including 23 samples and 43 prevalence rates) was 27% (95% CI: 21% -34%, I 2 : 99.6%) ( Table 2 ). This pooled prevalence represents a total of 22, 195 respondents. Several depression instruments were used: most frequently the Depression, . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 25, 2021. ; https://doi.org/10.1101/2021.06.21.21259227 doi: medRxiv preprint

The pooled prevalence of anxiety was 30% (95% CI: 24% -37%, I 2 : 99.6%) ( Table 2) .

Data from 18 studies (13-15, 17-26, 28-35) , including 22 samples and 44 prevalence rates), reported anxiety prevalence out of a total of 21,120 participants. The DASS-21 was used most frequently (56.5%), followed by Generalized Anxiety Symptoms 7-items scale (GAD-7) (30.4%), HADS (4.4%), and BSI (4.4%).

The aggregated prevalence of either anxiety or depression in frontline HCWs was 41% (95% CI: 23 -60%, I 2 : 99.4%) and 33% in general HCWs (95% CI: 22 -45%, I 2 : 99.4%) ( Table   2 ). The overall prevalence of mental health symptoms in Southeastern Europe countries was lower (27%, 95% CI: 22% -32%, I 2 : 99.4%) than in non-Southeastern Europe countries (32%, 95% CI: 24% -40%, I 2 : 99.7%) ( Table 2 ).

Subgroup analysis revealed that while depression prevalence was 34% for both general HCWs (95% CI: 18% -51%, I 2 : 99.5%) and frontline HCWs (95% CI: 2% -79%, I 2 : 99.5%), anxiety prevalence was significantly higher among frontline HCWs (46%; 95% CI: 25% -67%, I 2 : 99.4%) than among general HCWs (33%; 95% CI: 16% -51%, I 2 : 99.5%) ( Table 3 ). The prevalence of anxiety and depression in student populations was 31% and 32%, respectively. In the general population, prevalence of depression and anxiety was 20% and 22%, respectively (Table 3) .

European Union (EU) countries in Eastern Europe had a prevalence of 34% (95% CI: 27% -42%, I 2 : 99.7%), which is a bit higher than that Eastern European countries without EU memberships s (28%; 95% CI: 22% -35%, I 2 : 99.8%). Southeastern Europe countries (the greater Balkan region) had pooled anxiety and depression prevalence rates of 31% (95% CI: 23% -40%, I 2 : 99.5%) and 35% (95% CI: 21% -51%, I 2 : 99.4%), respectively (Table 3 ). In non-Southeastern Europe countries, prevalence of anxiety and depression was 29% (95% CI: 20% -40%, I 2 : 99.6%) and 55% (95% CI: 46% -65%, I 2 : 99.8%) ( Table 3) .

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 25, 2021.

Study quality was analyzed using the Mixed Methods Appraisal Tool (MMAT). Of the 21 studies, 3 studies (14.29%) were categorized as high quality and 18 studies (85.71%) categorized as medium quality ( Table 1 ). The subgroup analysis suggests the studies with high quality reported lower prevalence of clinically significant symptoms of mental health symptoms in Eastern Europe ( Table 2 ).

A sensitivity analysis was conducted using a DOI plot and Luis Furuya-Kanamori (LFK) index to detect any publication bias in the meta-analysis. Conventional funnel plots have been previously determined to be inaccurate for meta-analyses of pooled proportion studies (34) .

Additionally, DOI plots in combination with LFK indices use higher power and sensitivity for bias detection than both funnel plots and Egger's regression (36) . A DOI plot, in addition to a LFK index, can better graphically represent publication bias. An asymmetrical triangle indicates potential publication bias whereas a symmetrical triangle suggests no publication bias (36) . A LFK index score within ±1 indicates 'no asymmetry'. When the LFK index score exceeds ±1 but is within ±2 it indicates 'minor asymmetry' and when the score exceeds ±2 'major asymmetry' is indicated. The studies on Eastern Europe, as shown in Figure 3 , have 'minor asymmetry' based on an index score of 1.50 and therefore minor publication bias is likely. The impact of publication status and sample size was tested and no significant influence was found.

This meta-analysis on 21 empirical studies of 25,246 adults provides the first evidence on the pooled prevalence rates of mental health symptoms in Eastern Europe during the COVID-19

pandemic. The pooled prevalence rates of anxiety and depression in Eastern Europe were 30% . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 25, 2021. ; https://doi.org/10.1101/2021.06.21.21259227 doi: medRxiv preprint and 27% (Table 2) . Subgroup analyses revealed several key findings: frontline HCWs indicated higher rates of mental disorder symptoms, especially anxiety (46%, 95% CI: 25% -67%, I 2 :

99.4%), a high percentage of adults suffered from mild or greater severity of anxiety (56%, 95% CI: 44% -67%, I 2 : 99.4%), a higher rate of depression was found in non-Southeastern Europe (55%, 95% CI: 46% -65%, I 2 : 99.8%), and the choice of instruments represents a significant source of heterogeneity on the pooled prevalence of anxiety and depression symptoms.

First, we discuss the pooled prevalence rates of this meta-analysis by comparing them with prior meta-analytical findings during the COVID-19 pandemic in other regions as benchmarks. Our pooled prevalence of depression of 27% in Eastern Europe was within the range of similar meta-analyses results in China. Prior meta-analyses of depression in China indicated heterogeneous pooled prevalence ranging from 24% to 32% in adult populations (4, (37) (38) (39) . Our pooled prevalence of depression in Eastern Europe was significantly lower than prevalence in Southeast Asia (34%, p<0.001) (5), Spain (35%, p <0.001) (40) and Africa (45%, p <0.001) (41) and prevalence rates in a cross-continent meta-analysis including empirical studies from China, India, Iran, Iraq, Italy, Japan, Nepal, Nigeria, Spain, and the UK (34%, p <0.001) (42) .

The pooled prevalence of anxiety of 30% in this Eastern Europe meta-analysis was significantly higher than the pooled rates reported in Spain (20%, p <0.001) (40) and was similar to those among the general population in China (30%, p=0.653) (37) . However, prevalence of anxiety symptoms was significantly lower in Eastern Europe compared to prevalence in Africa (37%, p <0.001) (40) (41) and Southeast Asia (41%, p <0.001) (5), and to prevalence in a cross-. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 25, 2021. ; https://doi.org/10.1101/2021.06.21.21259227 doi: medRxiv preprint continent meta-analysis (i.e., China, India, Iran, Iraq, Italy, Japan, Nepal, Nigeria, Spain and the UK) (32%, p <0.001) (42).

Our results show that frontline HCWs suffered from anxiety symptoms at a significantly higher rate compared to other populations in Eastern Europe. Overall, frontline HCWs had the highest prevalence of mental health symptoms including anxiety (46%) and depression (34%), followed by general HCWs (anxiety: 33%, depression: 34%) and subsequently students (anxiety: 31%, depression: 32%) and the general population (anxiety: 22%, depression: 20%). This finding indicates heterogeneity of mental health symptoms among distinct populations in Eastern Europe. Comparatively, a meta-analysis in China also found a lower pooled prevalence of anxiety (27%) and depression (20%) among general HCWs compared to prevalence of anxiety (40%) and depression (24%) in frontline HCWs (43) . Notwithstanding this finding, it needs to be emphasized that there are heterogeneous results on the prevalence of psychopathology reported in HCWs in China (44) .

The prevalence of mental health symptoms during the COVID-19 pandemic is not homogeneous across regions. European Union (EU) countries in Eastern Europe had a prevalence of 34%, which a bit higher than that Eastern European countries without EU memberships at 28%. The greater Balkan region of Southeastern Europe and non-Southeastern Europe exhibited a similar rate of anxiety (31% vs. 29%) but a very different rate of depression symptoms (35% vs. 55%). Such mental health symptom differences provide important evidence for future research directions to offer insight into these significant differences. It is possible that the economic, cultural, social, and political factors of individual countries and broader regions as well as heterogeneous COVID-19 policies, such as the length and stringency of shutdowns, . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 25, 2021. ; https://doi.org/10.1101/2021.06.21.21259227 doi: medRxiv preprint lockdowns, and quarantine, may influence mental health symptoms such as anxiety and depression differentially (45) . We also note that the pooled prevalence rates of anxiety and depression are significantly influenced by the choice of the instruments in the primary studies.

For example, anxiety prevalence measured by DASS-21 was 25% (95% CI: 16% -34%, I 2 :

99.1%) and 43% using HADS (CI: 17% -71%, I 2 : 99.1%), suggesting future research should pay attention to the choice of the instruments.

The systematic review reveals that eleven Eastern European countries had not been subject to a single study on the topic. Future studies should focus on countries without empirical data including Armenia, Azerbaijan, Belarus, Georgia, Hungary, Moldova, Montenegro, North Macedonia, Romania, Slovakia, and Slovenia. For practical purposes, healthcare organizations in locations without country-level evidence on mental health may use our evidence at the regional level as approximate evidence. These findings also emphasize the importance of further empirical research and subsequent meta-analyses on Eastern Europe countries in order to better prioritize resource allocation.

The understanding of mental disorder prevalence within specific regions can help to create targeted healthcare policy by healthcare organizations such as WHO. The responses to the COVID-19 pandemic have been remarkably homogeneous across governments (45) . Available WHO guidance has focused on preventing local progression of infectious diseases rather than achieving regional herd behavior (45) . Eastern European mental healthcare is dependent on large psychiatric institutions with an emphasis on in-patient psychiatry (7), which may not be effectively addressing widespread anxiety and depression symptoms. Mental health research has historically been overlooked in Eastern Europe (7), where mental health epidemiology is still . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 25, 2021. ; https://doi.org/10.1101/2021.06.21.21259227 doi: medRxiv preprint regarded with intense stigma and direct evidence on the topic remains scarce (8) . Existing stigma, along with a lack of evidence-based community-wide mental health services, may be contributing to high prevalence of mental health disorders. Furthermore, recent changes in healthcare systems and lack of per capita funding for community mental health resources may contribute to the unique situation in Eastern Europe mental health, which still lacks evidencebased mental health practices (7) . With this backdrop, the meta-analysis provides quantitative evidence revealing a high prevalence of mental health symptoms in Eastern Europe serve as the basis for inform more targeted healthcare practices, such as evidence-based occupational guidelines which identify and focus on vulnerable populations during acute crises (2).

First, as we only included studies in English, there is an expected language bias. Second, our meta-analysis is limited by the limitations of the empirical studies. Due to the nature of lockdowns and social isolation during the pandemic, many of the studies used convenience samples, reducing the accurate representation of respective populations. Varying tools of data collection used different cut-off scores. In future research, mental health evaluation of a random sample would yield representative data. Additionally, the meta-analysis is limited by the populations and mental health symptoms represented in the available empirical studies. Only two studies covered insomnia, and therefore insomnia was not represented in the meta-analysis.

Further studies focused on insomnia prevalence would contribute to a pooled prevalence of insomnia and improve supporting data for evidence-based medical interventions.

Understanding the prevalence of mental health symptoms during the COVID-19

pandemic represents the first step to enable evidence-based medical practices by assessing the . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 25, 2021. ; https://doi.org/10.1101/2021.06.21.21259227 doi: medRxiv preprint mental health situation during the COVID-19 pandemic. We hope the meta-analysis in Eastern Europe can inform mental health practices as well as encourage future research on mental health during the ongoing COVID-19 pandemic. # An independent sample in a study may report anxiety, depression, and insomnia at the levels of mild above, moderate above, and severe. Hence, the total number of prevalence rates is larger than the total number of independent samples. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 25, 2021. ; https://doi.org/10.1101/2021.06.21.21259227 doi: medRxiv preprint

Publication bias in the baseline meta-analysis is graphically represented using a DOI plot along with a Luis Furuya-Kanamori (LFK) index score. A score of 1.50 indicates 'minor asymmetry' and therefore minor publication bias. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) "Coronavirus" OR "COVID-19" OR "SARS-CoV-2" OR "2019-nCoV"

Outcome of interest "Depression" OR "Depressive symptoms" OR "Depressive disorder*" OR "Anxiety" OR "Social anxiety" or "Social phobia" OR "Anxiety disorder" OR "Insomnia" OR "Sleep disorder" OR "Depressive disorder*"

Epidemiological phenomenon "Prevalence" OR "Incidence" OR "rate*" OR "ratio*" OR "Epidemiolog" OR "risk factor" OR "relative risk" OR "odds ratio" OR "risk ratio" OR "disease burden" 4 Language English

Intersection of four topics 1 AND 2 AND 3 AND 4

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

There are no conflicts of interest.

The corresponding author affirms this manuscript is an honest, accurate, and transparent account of the study being reported. No important aspects of the study have been omitted and any discrepancies from the study as planned (and, if relevant, registered) have been explained.

Not applicable.

University.

No patient or public was involved in this systematic review and meta-analysis.

The data that support the findings of this study are available from the corresponding author, J.C., upon reasonable request.

. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted June 25, 2021. ; https://doi.org/10.1101/2021.06.21.21259227 doi: medRxiv preprint

Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: A systematic review and meta-analysis

Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. The Lancet Psychiatry

Impact of COVID-19 pandemic on mental health in the general population: A systematic review

One Year of Evidence on Mental Health in China in the COVID-19

A Systematic Review and Meta-Analysis of the Mental Health Impact of the Covid-19 Pandemic in Southeast Asia

Prevalence of anxiety and depression in South Asia during COVID-19: A systematic review and meta-analysis

State of mental healthcare systems in Eastern Europe: do we really understand what is going on? BJPsych international

Covid-19, child and adolescent mental health -Croatian (in)experience

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers. Education for Information

Metaprop: a Stata command to perform meta-analysis of binomial data. Archives of Public Health

Cochrane handbook for systematic reviews of interventions

Differences in distress and coping with the Covid-19 stressor in nurses and physicians

Examining Anxiety, Life Satisfaction, General Health, Stress and Coping Styles During COVID-19 Pandemic in Polish Sample of University Students

Excessive Media Consumption About COVID-19 is Associated With Increased State Anxiety: Outcomes of a Large Online Survey in Russia

Dzubur Kulenovic A. Fear and depression among residents of Bosnia and Herzegovina during COVID-19 outbreak -internet survey

Quality of sleep and health-related quality of life among health care professionals treating patients with coronavirus disease-19

Increase in prevalence of current mental disorders in the context of COVID-19: analysis of repeated nationwide cross-sectional surveys

The Mediating Role of Insomnia and Exhaustion in the Relationship between Secondary Traumatic Stress and Mental Health Complaints among Frontline Medical Staff during the COVID-19 Pandemic

Adherence to safety and self-isolation guidelines, conspiracy and paranoia-like beliefs during COVID-19 pandemic in Poland -associations and moderators

Anxiety and depressive symptoms among healthcare professionals during the Covid-19 pandemic in Kosovo: A cross sectional study

Assessment of Mental Health Factors among Health Professionals Depending on Their Contact with COVID-19 Patients

Anxiety as a mediator of relationships between perceptions of the threat of COVID-19 and coping behaviors during the onset of the pandemic in Poland

Does greenery experienced indoors and outdoors provide an escape and support mental health during the COVID-19 quarantine? Environmental Research

COVID-19 Related Knowledge and Mental Health: Case of Croatia

Does Physical Activity Matter for the Mental Health of University Students during the COVID-19 Pandemic?

Is the mental health of young students and their family members affected during the quarantine period? Evidence from the COVID-19 pandemic in Albania

Predictors of emotional distress during the COVID-19 pandemic; a Croatian study

Public trust and media influence on anxiety and depression levels among skilled workers during the COVID-19 outbreak in Serbia. Vojnosanitetski pregled

Stress and Anxiety among Healthcare Workers Associated with COVID-19 Pandemic in Russia

Impact of COVID-19 pandemic on anxiety, depression and distress -online survey results amid the pandemic in Russia

Mental Health of Medical Workers During the COVID-19 Pandemic in Russia: Results of a Cross-Sectional Study. preprint

Mental health of medical personnel during the COVID-19 pandemic

Coronavirus Disease 2019 (COVID-19) Epidemic and Mental Health Status in the General Adult Population of Serbia: A Cross-Sectional Study

Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy

A new improved graphical and quantitative method for detecting bias in meta-analysis

Prevalence of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis

The psychological and mental impact of coronavirus disease 2019 (COVID19) on medical staff and general public -A systematic review and meta-analysis

Mental Health During the Covid-19 Outbreak in China: a Meta-Analysis. The Psychiatric Quarterly

A Systematic Review and Meta-Analysis on Mental Illness Symptoms in Spain in the COVID-19 Crisis

The Mental Health Under the COVID-19 Crisis in Africa: A Systematic Review and Meta-Analysis. medRxiv

Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Globalization and Health

Investigating the Psychological Impact of COVID-19 among Healthcare Workers: A Meta-Analysis

The Mental Health Effects of COVID-19 on Health Care Providers in China

A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker)

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

Mental Health Interventions during the COVID-19 Pandemic: A Conceptual Framework by Early Career Psychiatrists

A repeated cross-sectional survey assessing university students' stress, depression, anxiety, and suicidality in the early stages of the COVID-19 pandemic in Poland

Mental Health and the COVID-19 Pandemic: Hardiness and Meaningfulness Reduce Negative Effects on Psychological Well-Being

Structure of anxiety associated with the COVID-19 pandemic in the Russian-speaking sample: results from on-line survey. preprint

Mental Health of Medical and Non-Medical Professionals during the Peak of the COVID-19 Pandemic: A Cross-Sectional Nationwide Study

Epilepsy Care in the Time of COVID-19 Pandemic in Italy: Risk Factors for Seizure Worsening

Psychological Functioning of Patients Undergoing Oral Surgery Procedures during the Regime Related with SARS-CoV-2 Pandemic

The Attitudes and Professional Approaches of Dental Practitioners during the COVID-19 Outbreak in Poland: A Cross-Sectional Survey

What mental health experts in Slovakia are learning from COVID-19 pandemic?

The psychological typhoon eye effect during the COVID-19 outbreak in China: the role of coping efficacy and perceived threat. Globalization and Health

Symptoms of burnout in intensive care unit specialists facing the COVID-19 outbreak

Adjustment disorder, traumatic stress, depression and anxiety in Poland during an early phase of the COVID-19 pandemic

The role of socio-economic status in depression: results from the COURAGE (aging survey in Europe)

The Impact of the COVID-19 Pandemic in Central and Eastern Europe: The Rise of Autocracy and Democratic Resilience. Democratic Theory

Meta-analysis of Observational Studies in EpidemiologyA Proposal for Reporting

The relationship between age and mental health among adults in Iran during the COVID-19 pandemic

Succumbing to the COVID-19 Pandemic-Healthcare Workers Not Satisfied and Intend to Leave Their Jobs

Impact of coronavirus syndromes on physical and mental health of health care workers: Systematic review and meta-analysis

Understanding and Addressing Sources of Anxiety Among Health Care Professionals During the COVID-19 Pandemic

Mental health circumstances among health care workers and general public under the pandemic situation of COVID-19 (HOME-COVID-19)

Europe's War against COVID-19: A Map of Countries' Disease Vulnerability Using Mortality Indicators

Preparedness and Preventive Behaviors for a Pandemic Disaster Caused by COVID-19 in Serbia

Pathways to psychiatric care in Eastern Europe

Research, education and capacity building priorities for violence, abuse and mental health in low-and middle-income countries: an international qualitative survey. Social Psychiatry and Psychiatric Epidemiology

In meta-analyses of proportion studies, funnel plots were found to be an inaccurate method of assessing publication bias

P value-driven methods were underpowered to detect publication bias: analysis of Cochrane review meta-analyses

Central-Eastern Europe in Post-COVID-19 International Politics. International Trends / Mezhdunarodnye protsessy